TrimRx
TrimRx is a GLP-1-focused telehealth platform offering compounded semaglutide and compounded tirzepatide through an async care model. It entered the market around 2022 as the GLP-1 telehealth sector expanded rapidly, competing primarily on streamlined onboarding and pricing against larger platforms like Hims, Ro, and Found.
Overview
- Consultation Model
- Hybrid
- Headquarters
- United States
- Shipping
- 3-5 business days
- Lab Testing
- Yes
- Prescriber Info
- licensed physician reviews the intake and determines eligibility 3.
- Founded
- 2022
Pros
- GLP-1-only focus means the platform is designed around weight loss prescribing, not general primary care
- Streamlined async onboarding
- Competitive pricing on compounded GLP-1s (verify current rates at trimrx.com)
- No need to schedule or attend a video appointment
Cons
- Compounded GLP-1s face active FDA enforcement pressure in March 2026
- Async-only care model: no video consultation, no real-time interaction with provider
- No labs included or ordered through platform
- No structured titration protocol comparable to specialist programs like Calibrate or Sequence
- Newer, smaller platform relative to Hims, Ro, or Found
- If compounded supply is disrupted, no clear branded fallback pathway on-platform